HC Wainwright Cuts Zynex (NASDAQ:ZYXI) Price Target to $20.00

Zynex (NASDAQ:ZYXI – Get Rating) had its target price lowered by HC Wainwright from $21.00 to $20.00 in a report published on Tuesday, The Fly reports.

Separately, Piper Sandler raised shares of Zynex from a neutral rating to an overweight rating and raised their price objective for the stock from $10.00 to $18.00 in a research note on Friday, January 6th.

Zynex Stock Up 1.6 %

Shares of NASDAQ:ZYXI opened at $11.12 on Tuesday. The company has a current ratio of 3.41, a quick ratio of 2.68 and a debt-to-equity ratio of 0.10. Zynex has a 12 month low of $5.03 and a 12 month high of $17.25. The company has a 50-day moving average price of $13.63 and a 200 day moving average price of $12.15. The company has a market cap of $416.48 million, a price-to-earnings ratio of 25.27 and a beta of 0.65.

Zynex (NASDAQ:ZYXI – Get Rating) last announced its quarterly earnings results on Monday, March 13th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.01. Zynex had a net margin of 12.35% and a return on equity of 26.05%. The firm had revenue of $48.81 million during the quarter, compared to the consensus estimate of $49.65 million. As a group, equities research analysts predict that Zynex will post 0.43 earnings per share for the current year.

Institutional Trading of Zynex

Several institutional investors have recently added to or reduced their stakes in ZYXI. JPMorgan Chase & Co. lifted its stake in Zynex by 183.5% in the second quarter. JPMorgan Chase & Co. now owns 626,319 shares of the company’s stock worth $4,998,000 after purchasing an additional 405,396 shares during the last quarter. BlackRock Inc. increased its position in shares of Zynex by 12.7% during the first quarter. BlackRock Inc. now owns 3,419,912 shares of the company’s stock worth $21,307,000 after acquiring an additional 384,548 shares during the period. Federated Hermes Inc. increased its position in shares of Zynex by 1,148.0% during the first quarter. Federated Hermes Inc. now owns 222,563 shares of the company’s stock worth $1,387,000 after acquiring an additional 204,729 shares during the period. Rice Hall James & Associates LLC increased its position in shares of Zynex by 206.3% during the third quarter. Rice Hall James & Associates LLC now owns 203,921 shares of the company’s stock worth $1,850,000 after acquiring an additional 137,353 shares during the period. Finally, Renaissance Technologies LLC increased its position in shares of Zynex by 147.0% during the first quarter. Renaissance Technologies LLC now owns 192,035 shares of the company’s stock worth $1,196,000 after acquiring an additional 114,277 shares during the period. Institutional investors own 28.64% of the company’s stock.

About Zynex

(Get Rating)

Zynex, Inc engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.